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To define the bottlenecks that restrict antigen expression after oral administration of
viral-vectored vaccines, we tracked vectors derived from the human adenovirus type 5 at
whole body, tissue, and cellular scales throughout the digestive tract in a murine model
of oral delivery. After intragastric administration of vectors encoding firefly luciferase
or a model antigen, detectable levels of transgene-encoded protein or mRNA were
confined to the intestine, and restricted to delimited anatomical zones. Expression of
luciferase in the form of multiple small bioluminescent foci in the distal ileum, cecum, and
proximal colon suggested multiple crossing points. Many foci were unassociated with
visible Peyer’s patches, implying that transduced cells lay in proximity to villous rather
than follicle-associated epithelium, as supported by detection of transgene-encoded
antigen in villous epithelial cells. Transgene-encoded mRNA but not protein was readily
detected in Peyer’s patches, suggesting that post-transcriptional regulation of viral
gene expression might limit expression of transgene-encoded antigen in this tissue. To
characterize the pathways by which the vector crossed the intestinal epithelium and
encountered sentinel cells, a fluorescent-labeled vector was administered to mice by the
intragastric route or inoculated into ligated intestinal loops comprising a Peyer’s patch.
The vector adhered selectively to microfold cells in the follicle-associated epithelium, and,
after translocation to the subepithelial dome region, was captured by phagocytes that
expressed CD11c and lysozyme. In conclusion, although a large number of crossing
events took place throughout the intestine within and without Peyer’s patches, multiple
firewalls prevented systemic dissemination of vector and suppressed production of
transgene-encoded protein in Peyer’s patches.
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INTRODUCTION
Among the non-replicative viral vectors that have been explored
as vaccine carriers, those derived from human adenovirus type 5
(HAdV-5) have proven particularly effective in eliciting immune
responses against transgene-encoded antigen (Shiver et al., 2002).
Whereas this observation strictly concerns parenteral delivery
routes, orally-delivered vaccines are also sought, owing to their
ease of delivery in humans and other species and their potential
to elicit mucosal immunity. In this capacity, however, non-
replicative HAdV5-based vaccines have proven less effective.
Though oral administration of HAdV-5-based vaccines has given
rise to systemic immune responses against the transgene product
in multiple animal species, including rodents (Xiang Z. Q. et al.,
2003) and primates (Mercier et al., 2007), as well as in wild
and domestic species, such as foxes, dogs, and pigs (Hammond
et al., 2001, 2003; Tuboly and Nagy, 2001; Vos et al., 2001; Zhang
et al., 2008), they have been considered weak, especially in large
animals (Lubeck et al., 1989; Lin et al., 2007). Moreover, when
different delivery routes have been compared in the same trial,
higher doses have generally been required to afford protection by
the oral route (Ertl, 2005).
The bottlenecks to efficient induction of immune responses
after oral delivery of HAdV-5-based vaccines remain ill-defined.
Instability in the gastric environment diminishes the dose of
viable vector that reaches the small intestine, but cannot be
the only limiting factor, since even when the stomach has
been bypassed by enteric administration in sheep or endoscopic
deposition in the small intestine of dogs, adaptive immune
responses remained weak (Mutwiri et al., 2000) or undetectable
(Vos et al., 2001), respectively. A high affinity receptor for
HAdV-5, the coxsackievirus and adenovirus receptor (CAR)
(Bergelson et al., 1997), and major internalization co-receptors,
the αv integrins (Wickham et al., 1993), have been implicated
in transduction of highly permissive cell lines. These molecules,
however, are only weakly expressed at the apical surface of
differentiated intestinal epithelial cells, presumably limiting their
transduction by luminal HAdV-5 particles (Hamilton et al., 1997;
Walter et al., 1997; Croyle et al., 1998a,b; Lecollinet et al., 2006;
Kesisoglou et al., 2010). Even once the mucosal barrier has
been overcome, the tolerogenic context of the intestinal milieu
may represent an additional bottleneck, and indeed systemic
IgG responses elicited against a transgene-encoded antigen were
substantially enhanced when an intragastrically delivered HAdV-
5-derived vector encoded a Toll-like receptor 3 ligand (Scallan
et al., 2013).
The transfer of vaccinal antigen to professional antigen-
presenting cells, and notably to dendritic cells (DCs), has
emerged as a determinant factor in vaccine efficacy (Steinman,
2012). Such transfer is particularly critical in oral vaccine
delivery, since the barrier function of the gastrointestinal mucosa
restricts translocation of luminal antigen across the epithelium,
and thus its recovery by underlying DCs. Nevertheless, once
introduced into the gut, antigen may be transported across both
follicle-associated epithelium (FAE) and the villous epithelium
(for a review see Schulz and Pabst, 2013). The FAE overlies
clusters of lymphoid follicles, called Peyer’s patches, and
is distinguished by the presence of specialized transcytotic
cells, called microfold (M) cells. M cells actively transport
particulate luminal antigen toward the subepithelial dome (SED)
region (Owen, 1999; Neutra et al., 2001), where a myriad
of mononuclear phagocytes lie in wait. In villous epithelium,
immunoglobulin-bound antigen may be transported from the
lumen to the lamina propria by antigen-shuttling receptors
of epithelial cells (Yoshida et al., 2004) or, as proposed in a
recent study (McDole et al., 2012), by goblet cells. Moreover,
dendritic extensions of phagocytic cells can penetrate the villous
epithelium by the paracellular pathway and capture particulate
antigen at the luminal surface of epithelial cells or in the lumen
(Farache et al., 2013). For several enteric viruses, including
reovirus (Wolf et al., 1981) and norovirus (Gonzalez-Hernandez
et al., 2014; Kolawole et al., 2015), Peyer’s patches—and in some
instances, M cells—have explicitly been shown to play a major
role in entry of luminal virus, but this possibility remains to be
addressed for HAdV5.
In order to improve the immunogenicity of orally-delivered
HAdV-5-based vectors, a better understanding of their fate
in the intestinal milieu is a prerequisite. To provide a global
vision of transgene expression in the intestine, bioluminescence
imaging of the entire digestive tract was performed in mice after
intragastric administration of a HAdV-5-based vector encoding
firefly luciferase. In complementary experiments, quantitative
RT-PCR was performed in the intestine and in peripheral
tissues after intragastric delivery of vector. Finally, in order
to characterize the pathways by which the vector traverses
the intestinal epithelium and is captured by sentinel cells, a
fluorescent-labeled vector was administered to mice by the
intragastric route or inoculated into ligated intestinal loops
comprising a Peyer’s patch. These studies have allowed us to
trace the route taken by intragastrically delivered HAdV-5-
based vectors from the lumen of the intestine to gut-associated
lymphoid tissue.
MATERIALS AND METHODS
Mice
Animal experimentation was conducted in compliance with
European and institutional guidelines and approved by the local
ethics committee (ComEth Anses/ENVA/UPEC: 20/12/12-26B).
Female C57Bl/6 and BALB/c mice were purchased from Charles
River Laboratories and housed under specific pathogen-free
conditions. Mice were 8 weeks of age at the beginning of each
protocol.
Cell Culture
The human embryonic kidney cell line HEK-293 (Graham et al.,
1977), used for propagation and titration of HAdV-5-based
vectors, was cultivated in Dulbecco’s modified Eagle’s medium
containing 4mM L-alanyl-L-glutamine dipeptide (GlutaMax)
and supplemented with 1mM pyruvate, 10% heat-inactivated
fetal calf serum (FCS) (Eurobio), 100 IU/ml penicillin and
100µg/ml streptomycin (complete DMEM medium). Cells were
maintained at 37◦C in the presence of 5% CO2.
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Adenovirus-Based Vectors
Vectors were derived from E1- and E3-deleted HAdV-5; Ad5-
ova (Suleman et al., 2011), Ad5-luc (Havenga et al., 2001),
and Ad5-gfp (the kind gift of Michael Barry; Parrott et al.,
2003) expressed chicken ovalbumin (ova), firefly luciferase (luc),
and green fluorescent protein (GFP), respectively, under the
control of the intermediate-early cytomegalovirus (IE-CMV)
promoter (full-length for Ad5-ova and -gfp and minimal for
Ad5-luc). These were amplified in HEK-293 cells and purified
by two rounds of CsCl gradient ultracentrifugation. Vectors
were desalted by gel filtration on columns (Disposable PD-10
Desalting Column with Sephadex G-25 resin, GE Healthcare)
equilibrated with phosphate-buffered saline (PBS). Following
addition of glycerol (10%, v/v), vectors were aliquoted and
stored at −80◦C. The concentration of viral physical particles
was determined by measurement of absorbance at 260 nm,
after dilution of the viral suspension in sodium dodecyl sulfate
(1% final concentration) and incubation at 100◦C (Sweeney
and Hennessey, 2002). Infectious titers were determined by
endpoint dilution in HEK-293 cells (Reed and Muench, 1938).
The presence of a cytopathic effect was assessed under light
microscopy and titers were expressed as median tissue culture
infective doses (TCID50).
Immunization of Mice with Ad5-ova
The ova-specific humoral response elicited after administration
of the Ad5-ova vector by intragastric and intramuscular delivery
routes was assessed by ELISA. Groups of five C57Bl/6 mice were
immunized with 5 × 106 or 5 × 108 TCID50 of Ad5-ova in
100 µl of PBS at days 0 and 28. As a positive control, a third
group received 300 µg of purified ova (Grade 5, Sigma-Aldrich),
along with 10 µg of cholera toxin (Sigma-Aldrich), in 100 µl of
PBS at days 0, 7, 14, and 28 by the intragastric route. A feeding
needle was used for intragastric delivery, andmice were fasted for
approximately 12 h prior to administration. For intramuscular
delivery 50 µl of inoculum was inoculated into each hind limb
for both prime and boost. Blood was collected 1 week prior to
immunization and then at 2-week intervals from day 0 on, for
preparation of serum.
Each well of 96-well microplates (Maxisorp, Nunc) was coated
with 2 µg of ova in 100 µl of carbonate-bicarbonate buffer
(0.05M, pH 9.6) and incubated overnight at 4◦C. Plates were
then washed with PBS containing 0.05% Tween 20 (PBS-Tween),
as for all subsequent washes. Plates were blocked by incubation
with 200 µl of PBS containing 1% bovine serum albumin (BSA)
and incubated for 2 h at room temperature. After washing, 100
µl volumes of dilutions of mouse sera prepared in PBS-Tween
containing 1% BSA (PBS-Tween-BSA) were added and incubated
for 2 h at room temperature, as were serial dilutions of a murine
monoclonal antibody (mAb) recognizing ova (Sigma-Aldrich,
clone OVA-14). After washing, 100 µl volumes of a 1/8000
dilution of horseradish peroxidase-conjugated goat F(ab’)2 anti-
mouse pan-Ig (SouthernBiotech) in PBS-Tween-BSA were added
and incubated for 1 h at room temperature. After washing, 100µl
volumes of 3,3′,5,5′-tetramethylbenzidine substrate (Invitrogen)
were added and absorbance was measured 15min later at 405 nm
after addition of 100 µl of 1M HCl. A standard curve was
constructed in which absorbance was plotted as a function of
the concentration of anti-ova mAb. Anti-ova titers in mouse sera
were expressed as the concentration of anti-ova antibody, by
reference to the standard curve.
Evaluation of Transgene Expression by
Bioluminescence
Mice were fasted for ∼12 h prior to experiments. Ad5-luc was
adjusted to 2.5 × 109 TCID50/ml in PBS. Fasted mice were
anesthetized with isoflurane prior to intragastric administration
of 200 µl of Ad5-luc (5 × 108 TCID50) by means of a feeding
needle. Twenty-four hours later, the mice were anesthetized by
intraperitoneal injection of ketamine (100 mg/kg) and xylazine
(10 mg/kg). A volume of 100 µl of D-luciferin (30 mg/ml
in PBS) was then administered by intraperitoneal injection (2
sites of injection), so as to administer 150 mg/kg, or 3mg for
a mouse weighing 20 g. After 5min, bioluminescence imaging
was performed on live mice (BALB/c only) and—following
euthanasia and rapid dissection of mice—on the entire intestine
by using the IVIS 200 imaging system (PerkinElmer). Living
Image software (version 4.0, PerkinElmer) was used both to
acquire bioluminescent and photographic images and perform
analyses. Bioluminescent images were acquired for 1min with
f/stop and binning settings of 1 and medium, respectively,
from which background bioluminescence was subtracted. For
analysis of bioluminescence, image data were displayed as
photons, and regions of interest (bioluminescent foci) were
drawn using the automatic function, such that only regions
in which the number of pixels exceeded an automatically
determined threshold were retained. Data acquired for each focus
included its average radiance [in photons/s/cm2/steradian (sr)],
its surface area (in cm2), and its photon flux (in photons/s),
the latter being equal to the product of the average radiance,
the surface area, and 4pi. For each anatomical region, the
number of foci was determined by overlaying bioluminescent
and photographic images, and average radiance and average
surface area of foci by determining the arithmetic mean of the
radiance and surface area of individual foci. Total photon flux
(in photons/s) in each anatomical region was determined by
summing the photon flux for individual foci observed within the
region.
Evaluation of Transgene Expression by
Reverse Transcription Quantitative PCR
Ad5-ova was adjusted to 2.5 × 109 TCID50/ml in PBS and a 200
µl volume (5 × 108 TCID50) was administered to fasted mice
(three per strain) by the intragastric route as described above.
Twenty-four hours later, the mice were euthanized and organs—
intestine, MLNs, spleen, and a small lobe of liver—collected.
Peyer’s patches, identified by visual observation, were excised
and reserved. Intestinal contents were removed by flushing with
ice-cold PBS. Short sections of duodenum, jejunum, and ileum,
as well as the entire cecum, were collected from the intestine.
Intestinal and extra-intestinal tissue samples were stored in
RNAlater stabilization solution (Ambion) at−20◦C.
For isolation of RNA, tissue samples—15–20mg or entire
Peyer’s patches and MLNs—were minced and disrupted in
0.6ml of lysis buffer (RLT solution, Qiagen) containing 1%
(v/v) β-mercaptoethanol (β-ME), by using a tissue homogenizer
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and ceramic lysing beads (Fast Prep-24 instrument and Lysing
matrix D, both of MP Biomedicals). The lysate was clarified by
centrifugation for 3min at 10,000× g, and total RNAwas isolated
from the supernatant by using commercially available materials
(RNeasy Mini Kit, Qiagen) according to the recommendations
of the manufacturer. Residual DNA was removed by on-column
DNase digestion using the RNase-Free DNase Set (Qiagen).
The absorbance of the RNA samples was measured at 260 and
230 nm, to provide an estimation of quantity (260 nm) and purity
(260/230 nm) (NanoDrop 2000, Thermo Scientific).
Transgene-specific (ova) mRNA was quantified by
reverse transcription quantitative PCR (RT-qPCR) by using
commercially available reagents (SuperScript R©One-Step RT-
PCR System with Platinum R©Taq DNA polymerase, Invitrogen)
and a Light cycler 96 instrument (Roche). Primers and TaqMan
probes specific for ova and murine β-actin were purchased
from ThermoFisher Scientific (Taqman Gene Expression Assays
FAM-MGB Gg03366804_m1 and VIC-MGB Mm00607939_s1,
respectively). Ova and β-actin mRNA were amplified in separate
reactions, since preliminary experiments had shown that the
sensitivity of detection of ova transcripts was diminished in a
multiplex context. Relative gene expression was determined by
the 2−11CT method (Livak and Schmittgen, 2001). Briefly, the
threshold cycle (Ct) for the ova target gene was normalized to
that of the β-actin internal control gene and then expressed
relative to that of a calibrator tissue, corresponding to the tissue
for which the lowest level of ova mRNA was detected. The
quantity of ova mRNA was thus expressed as fold difference as
regards that of the common calibrator tissue.
Simultaneous Detection of Luc mRNA and
Enzymatic Activity
Ad5-luc was adjusted to 2.5 × 109 TCID50/ml in PBS and a
200 µl volume (5 × 108 TCID50) was administered to a group
of five fasted mice by the intragastric route as described above.
Twenty-four hours later, tissue samples—∼50mg of distal ileum
and apex cecum and entire Peyer’s patches—were collected as
described above and maintained in culture medium on ice.
Peyer’s patches were pooled for each mouse. Tissue samples were
minced (except Peyer’s patches) and then suspended in 600 µl of
lysis buffer [25mMTris pH 7.8, 8mMMgCl2, 0.1% Triton X-100
(v/v), 15% glycerol (v/v)] and immediately lysed as described for
quantification of ova mRNA.
To recover RNA, a 300 µl volume of lysate was combined
with 600 µl of lysis buffer (with β-ME) for RNA extraction
(RNeasy Mini Kit, Qiagen) and frozen at −20◦C until thawed
for extraction of RNA as previously described for quantification
of ova mRNA. Transgene-specific mRNA (luc) was quantified
by RT-qPCR, as described for ova mRNA but with primers and
TaqMan probe specific for luc (Taqman Gene Expression Assay
FAM-MGB Mr03987587_mr, Thermo Fisher Scientific). Relative
gene expression was determined by the 2−11CT method as
described for ovamRNA. To quantify luc activity, the remaining
lysate (∼300 µl) was maintained on ice for 30min. The lysate
was transferred to a fresh centrifuge tube and clarified by
centrifugation for 3min at 10,000× g. Supernatant was stored at
−20◦C until analysis. Protein concentration and luc activity were
determined by using commercially available reagents (Pierce
BCA Protein Assay Kit, Thermo Fisher Scientific and Bright-
Glo Luciferase Assay System, Promega, respectively), and for the
latter, by using the IVIS 200 imaging system (PerkinElmer).
Localization of Transgene Expression by
Immunohistochemistry
Twenty-four hours after intragastric administration of Ad5-luc
or co-administration of Ad5-luc and Ad5-gfp vectors, intestines
were removed and thoroughly rinsed as described above.
Tissue samples—apex cecum and portions of the distal ileum
comprising Peyer’s patches—were collected and immediately
fixed in PBS-4% paraformaldehyde for 2 h at room temperature.
Tissues were pre-embedded by incubation in PBS containing 12%
sucrose for 3 h at 4◦C, followed by overnight incubation in PBS
containing 20% sucrose at 4◦C. The tissues were then embedded
in Tissue-Tek optimal cutting temperature compound (O.C.T.)
and snap-frozen in isopentane chilled in the vapor phase of liquid
nitrogen. Frozen tissue sections (7µm) were prepared by using
a cryostat (Leica CM3050 S) and deposited on slides (Superfrost
Ultra Plus, Thermo Scientific). Slides were stored at −20◦C until
use.
For immunolabeling, slides were washed for 5 to 10min
in PBS to remove O.C.T. Sections were encircled by using a
hydrophobic marker and then blocked with PBS containing 5%
goat serum and 2% BSA for 15min at room temperature (100
µl/section). After rinsing with PBS, the sections were labeled
overnight at 4◦C with rabbit serum directed against firefly luc
(Abcam, ab21176), diluted to 1/400 in PBS 0.3% BSA (10µg/ml
final; 50 µl/section). As a negative control, certain sections were
incubated with non-immune rabbit serum diluted in the same
manner. After three washes in PBS, endogenous biotin was
blocked by using commercially available reagents (Endogenous
biotin-blocking kit, Molecular Probes-Life Technologies, E-
21390), according to the manufacturer’s recommendations. After
three washes with PBS, the sections were incubated for 1 h at
room temperature with a biotin-conjugated secondary antibody
directed against rabbit IgG (Biotin-Mouse anti-rabbit IgG (H
+ L), Thermo Scientific # 31824), diluted 1/100 in PBS 0.3%
BSA (50 µl/section). After three washes with PBS, the sections
were incubated for 30min at room temperature with Alexa
Fluor 555-conjugated streptavidin (Life Technologies, S32355)
diluted 1/1000 (2µg/ml final) in PBS 0.3% BSA (50 µl/section).
After three washes in PBS, the sections were labeled with 4′,6-
diamidino-2-phenylindole (DAPI) (1µg/ml final; 50 µl/section)
for 10min at room temperature. After two washes, one with
PBS and the second with water, the sections were mounted
in Immu-Mount medium (Thermo Scientific) for observation
under fluorescence microscopy.
Fluorescent Labeling of HAdV-5
Particles of Ad5-luc or Ad5-ova were labeled with the
fluorescent probe Alexa Fluor 488 by using Alexa Fluor
488 5-SulfodichloroDP ester (Invitrogen), according to the
manufacturer’s recommendations. Briefly, 50 µl of a 1mM
solution of Alexa Fluor 4885-SDP ester in DMSO was prepared
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to which a 0.5ml volume of a viral suspension containing 1012
physical particles of a HAdV-5 vector in 1M sodium bicarbonate
buffer (pH 8.5) was immediately added. After 1 h at room
temperature, labeled virus (Alexa488-Ad5) was separated from
free dye using a gel filtration column (ZebaTM desalt spin
columns, Pierce Biotechnology).
Tracking Fluorescent-Labeled HAdV-5 in
Ligated Intestinal Loops
Ligated intestinal loops were prepared in BALB/c mice as
previously described (Rey et al., 2004). Briefly, Alexa488-Ad5-
ova was adjusted to 1 × 1012 physical particles/ml and a 100 µl
volume (1 × 1011 PP or ∼1 × 108 TCID50) injected into the
lumen of the ligated loop using a 1ml U-100 insulin syringe.
After 1 or 4 h, mice were sacrificed and the ligated intestinal
loop was recovered. After extensive washing with 20ml of ice-
cold PBS, the loop was fixed by immersion in 1ml of PBS-4%
paraformaldehyde for 2 h at room temperature. The tissue was
pre-embedded, embedded in O.C.T. compound and snap-frozen,
as described above. Frozen sections (7µm) were prepared as
described above. Sections were washed two times for 10min in
200ml of PBS at room temperature. Slides were stored at −20◦C
until thawed for staining.
Immunolabeling was performed in the dark to preserve
fluorescence. Slides were washed for 15-20min in PBS with
mild rotation to remove O.C.T. and then blocked using 5%
FCS for 15min. After a single wash in PBS, sections were
blocked using commercial Fc block CD16/32 (BD Biosciences)
at 1/300 dilution for ∼10min. Slides were then washed once in
a large volume of PBS and allowed to dry before labeling. For
labeling DCs, biotin-conjugated anti-CD11c mAb (clone HL3,
BD Biosciences) was applied at a 1/10 dilution overnight at
4◦C. Slides were washed briefly without agitation and incubated
with the secondary reagent, streptavidin-Cy5 (Amersham), at
1/500 dilution for 30min. Nuclei were stained with DAPI at
the same time as the secondary reagent using commercial
DAPI stain (InVitrogen) at 1/300 dilution. After staining the
slides were washed as described earlier and dried. On selected
sections, M-cell staining was performed using rhodamine-labeled
Ulex europaeus agglutinin-1 (UEA-1) (Vector Laboratories) at
1/50 dilution. Finally, VectaShield was added to sections before
applying cover slips. The slides were visualized by laser scanning
confocal microscope (Carl ZEISS; LSM 710) using Zen 2009
imaging software.
Tracking Fluorescent-Labeled HAdV-5 after
Intragastric Administration
Alexa488-Ad5-luc was adjusted to 1 × 1012 physical particles/ml
in PBS and a 200 µl volume (2 × 1011 PP or ∼1 × 109
TCID50) was administered to fasted C57Bl/6 and BALB/c mice
by the intragastric route as described above. Twenty-four hours
later, mice were euthanized and luc expression was evaluated in
intact intestinal tissues by bioluminescence imaging as described
above. For mice displaying visible bioluminescent foci, the apex
cecum, and Peyer’s patches were collected and prepared for
cryosecting. For immunolabeling, sections were blocked and
endogenous biotin quenched, as described for localization of
transgene expression. Sections were then labeled overnight at
4◦C with biotin-conjugated anti-mouse CD11c (clone HL3, BD
Biosciences) and rabbit anti-human lysozyme (Dako), diluted
1/10 and 1/200, respectively, in PBS 0.3% BSA (50 µl/section).
For negative controls sections were labeled with non-immune
rabbit serum (1/400 dilution). After washing three times, sections
were incubated with secondary reagents: Alexa Fluor 647-
conjugated goat anti-rabbit IgG and Alexa Fluor 555-conjugated
streptavidin (both from Molecular probes), diluted 1/200 and
1/1000, respectively, in PBS 0.3% BSA (50 µl/section). After
washing three times, sections were stained with DAPI and
mounted as described for localization of transgene expression.
The slides were visualized by laser scanning confocal microscopy,
using a LEICA SP5 instrument equipped with a HCX PL Apo CS
63X NA1.4 objective.
Statistical Analysis
Two-way ANOVA was used to evaluate the impact of anatomic
location and mouse strain on total photon flux, number of
bioluminescent foci and their average radiance and surface area.
Multiple pairwise comparison of means was then performed by
using the Tukey method. As regards the impact of anatomic
location on quantity of luc-specific mRNA and specific activity,
medians were first compared by using the Kruskal–Wallis test.
When different, these were compared pair-wise by applying
the Wilcoxon-Mann-Whitney test and Bonferroni correction for
multiple comparisons. Analyses were performed by using R (R
Core Team, 2017) or GraphPad Prism software, version 6.0c
(GraphPad Inc, San Diego, CA, USA).
RESULTS
Intramuscular but Not Intragastric
Administration of Ad5-Ova elicits
Circulating Ova-Specific Antibodies in
Mice
The efficiency with which Ad5-ova elicits antibodies (including
IgG, IgM, and IgA) directed against ova was compared in mice
after intragastric (ig) and intramuscular (im) administration
(Figure 1). After im delivery of 5 × 108 TCID50 of Ad5-ova,
all mice had readily detectable titers of anti-ova antibodies in
serum as early as 2 weeks after the first administration and at all
subsequent time points (Figure 1i), whereas anti-ova antibodies
were not detected in any of themice at any time after ig delivery of
the same dose (Figure 1ii). A robust anti-ova humoral response
was nonetheless obtained in control mice after ig administration
of soluble ova in the presence of the CT adjuvant (Figure 1iii).
Of note, while this last regimen elicited a measurable pan-
Ig (IgG, IgM, and IgA) response against ova in the intestinal
compartment, as measured in fecal extracts, administration of
Ad5-ova, irrespective of delivery route, did not (data not shown).
Induction of a systemic humoral response by non-replicative
HAdV-5-based vaccines was thus vastly less effective by the ig
than im delivery route as, similar to previous observations made
in mice for other transgene-encoded antigens (Vos et al., 2001;
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Xiang Z. et al., 2003). Indeed, im administration of even 5 ×
106 TCID50 of Ad5-ova, a 100-fold lower dose, sufficed for
induction of a robust humoral immune response directed against
the transgene product (data not shown).
After Intragastric Administration of
Ad5-luc, the Level of Transgene Expression
Peaks after ∼24 h
AHAdV-5-based vector (Ad5-luc) encodingfirefly luciferase (luc)
was delivered to BALB/c mice by the ig route and transgene
expression was evaluated at different time points thereafter by in
vivo bioluminescence imaging. Though transgene expression was
readily observed in the hind limb after im delivery of the same
quantity of vector (Figure 2A), themagnitude of bioluminescence
observed in the abdominal region after ig administration was
inferior by approximately three logs (Figure 2B). The highest
values were obtained at the first time point examined, 24 h
(Figure 2C). Earlier time points were next examined after ig
delivery of Ad5-luc to C57Bl/6 mice, and after euthanasia and
dissection, bioluminescence could be observed in the abdominal
cavity at 24 and 30 h time points (Figure 2D). In view of these
results, the 24 h time pointwas selected for all subsequent analyses
of transgene expression by bioluminescence imaging.
FIGURE 1 | Comparison of humoral responses elicited after intramuscular and intragastric administration of an adenovirus-based vector in mice. A non-replicative
HAdV-5-based vector expressing chicken ovalbumin (Ad5-ova) was administered to groups of five C57Bl/6 mice at day 0 and 28 by the intramuscular (i) or
intragastric (ii) route, and, as a positive control, soluble ova with CT was administered at day 0, 7, 14, and 28 by the intragastric route (iii). Anti-ova Ig in sera was
measured by ELISA on immobilized ova. Responses were determined in reference to a standard curve constructed for a mouse mAb directed against ova, and
expressed as concentration of mAb. Data for the high dose of Ad5-ova (5 × 108 TCID50) are shown in (i,ii).
FIGURE 2 | Temporal transgene expression after intragastric administration of an adenovirus-based vector in mice, as revealed by bioluminescence imaging. A
non-replicative HAdV-5-based vector (Ad5-luc) expressing firefly luciferase was administered (5 × 108 TCID50) to mice by intramuscular (A) and intragastric (B–D)
routes. Twenty-four hours later or at different time points thereafter for intramuscular and intragastric administration, respectively, anesthetized mice received D-luciferin
by the intraperitoneal route. Approximately 5min later, photon emission was detected by means of the IVIS 200 imaging system (Xenogen) for live BALB/c mice (A–C),
or following euthanasia and rapid dissection of mice, for the entire intestinal tract of C57Bl/6 mice (D). (A) Bioluminescence was analyzed by using Living Image
software and expressed as radiance in photons/second/cm2/steradian (A,B) or photon flux in photons/second (C,D), for a single user-defined abdominal zone in (C)
or as the sum of automatically drawn bioluminescent foci in (D). The representative BALB/c mouse shown in (B) received the vector 24 h earlier. Arithmetic means ±
SEM for pairs of mice (except the 72 h time point concerning a single mouse) are shown in (C); Boxes in (D) depict arithmetic means with maximum and minimum
values for groups of three mice.
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After Intragastric Administration of
Ad5-Luc, Transgene Expression–as
Determined by Bioluminescence
Imaging—Is Confined to the Intestine but
Varies according to the Anatomical Region
After ig inoculation of Ad5-luc, C57Bl/6, and BALB/c mice were
dissected to expose the viscera for bioluminescence imaging.
Transgene expression was never observed in extra-intestinal
tissues such as liver and spleen, and not even in the mesenteric
lymph nodes (MLNs) to which intestinal tissues drain (data not
shown). Bioluminescence was, however, observed throughout the
intestinal tract—and more particularly within the distal small
intestine (ileum), the cecum, and proximal colon—taking the
form of multiple small foci (Figure 3A).
For the purpose of analysis, we made the assumption that the
bioluminescent foci corresponded to instances of translocation
and transduction of intestinal target cells and that photon flux
was related to the level of transgene expression. We further
assumed that the number of foci reflected the number of
productive—that is, leading to transduction—crossings, that the
radiance of foci was related to the density of transduced cells
and/or their level of transgene expression and, finally, that
the surface area was related to the extent of the transduced
zone. Based on these considerations, the total photon flux,
number of foci, radiance, and surface area were compared for
three anatomical zones—namely, the small intestine, cecum and
colon—for C57Bl/6 and BALB/c mice (Figure 3B) mice.
Comparison of these four variables by two-way ANOVA
revealed statistically significant variation according to anatomic
location but not to strain of mouse. Total photon flux was higher
in the cecum and small intestine than in the colon (Figure 3Bi).
The number of foci was also greater in the cecum and small
intestine than in the colon, with greater numbers found in the
FIGURE 3 | Anatomy of transgene expression after intragastric administration of an adenovirus-based vector in mice, as revealed by bioluminescence imaging. As
described in the legend of Figure 2, mice received Ad5-luc (5 × 108 TCID50) by the intragastric route and D-luciferin 24 h later. Mice were euthanized 5min later and
rapidly dissected to display the entire intestine. Photon emission was detected as described in the legend of Figure 2. (A) Magnification of the resulting images
reveals multiple bioluminescent foci in cecum and ileum of C57Bl/6 (i,ii) or BALB/c (iii,iv) mice. (B) Foci of C57Bl/6 and BALB/c mice were analyzed by using Living
Image software and attributed to various intestinal tissues (small intestine, cecum, and colon). Data are expressed for individual tissues as total photon flux (sum of the
photon flux of individual bioluminescent foci) (i), number of foci (ii), average radiance of foci (iii), and average surface area of foci (iv). Boxes of box and whisker plots
show 25, 50, and 75th percentiles. Whiskers are drawn according to the Tukey method. For each mouse strain, data from two independent experiments involving four
mice/experiment have been pooled. Arithmetic means were compared by the Tukey method: *P < 0.05; **P < 0.01; ***P < 0.001.
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cecum than in the small intestine (Figure 3Bii). The radiance of
foci was also higher in the cecum than in the small intestine, but
with no discernible difference between these tissues and the colon
(Figure 3Biii). Regarding the surface area, the foci of both cecum
and small intestine were significantly larger than those found in
the colon, though those of the small intestine were larger than
those of the cecum (Figure 3Biv).
Taken together, the total photon flux—and thus presumably
the magnitude of transgene expression—was similarly high in
the small intestine and cecum, the crossing events (number of
foci) in the cecum being more frequent and leading to a greater
intensity of transgene expression (radiance), while those in the
small intestine giving rise tomore extensive zones of transduction
(surface area).
After Intragastric Administration of
Ad5-Ova, Transgene Expression—as
Determined by RT-qPCR—Is Confined to
the Intestine but Varies According to the
Anatomical Region
Detection of bioluminescence requires not only sufficient
expression of transgene-encoded luc, but also sufficient diffusion
of the D-luciferin substrate and adequate concentrations of the
enzymatic co-factors of luc; that is, O2 and ATP. We therefore
studied the anatomy of transgene expression by a second
technique that was free from these constraints. In particular,
after ig delivery of Ad5-ova to C57Bl/6 and BALB/c mice, ova-
specific mRNA was quantified by RT-qPCR in tissues collected
throughout the intestine (Figure 4A), as well as in extra-intestinal
tissues.
Similar to results obtained when transgene expression was
tracked by bioluminescence imaging, detectable levels of ova
mRNA were not observed in extra-intestinal tissues, even in the
MLNs that drain intestinal tissue, at 24 and 48 h (data not shown).
For both C57Bl/6 (Figure 4Bi) and BALB/c (Figure 4Bii) mice,
however, ova transcripts were detected throughout the intestinal
tract, including not only the cecum (and more particularly the
blind end of the cecum, or “apex ceci”) and colon, but also Peyer’s
patches, to which bioluminescent foci had rarely been attributed.
Moreover, relatively little transgene expression was detected in
the segments of the small intestine examined, although this tissue
had appeared to be a major site of transgene expression when
appreciated by bioluminescence imaging (Figure 3B).
After Intragastric Administration of
Ad5-luc, the Relationship between the
Magnitude of Bioluminescence and the
Quantity of luc mRNA Varies According to
the Anatomical Region
Depending upon the gene product (mRNA or protein) used
to appreciate transgene expression—bioluminescence imaging
or RT-qPCR—the relative levels of transgene expression in
FIGURE 4 | Anatomy of transgene expression after intragastric administration of an adenovirus-based vector in mice, as revealed by RT-qPCR. A non-replicative
HAdV-5-based vector (Ad5-ova) expressing ova was administered (5 × 108 TCID50) to mice (three per strain) by the intragastric route. Twenty-four hours later mice
were euthanized and tissues were collected from different anatomical zones of the intestine (sampling sites indicated by italicized text) as well as from extra-intestinal
organs (mesenteric lymph nodes, spleen, liver) (A). (B) Total RNA was extracted from tissue and ova and β-actin transcripts were quantified by RT-qPCR for C57Bl/6
(i) and BALB/c (ii) mice. The relative expression level of ova RNA was determined by the 211CT method; that is, after normalization against β-actin transcripts and
relative to that of a positive internal reference tissue, and expressed as relative units. Arithmetic means are indicated.
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different tissues appeared to be different; that is, relatively
high levels of expression in small intestine by bioluminescence
imaging but in Peyer’s patches by RT-qPCR. To determine
whether this difference was related to the use of HAdV-5-
based vectors expressing different transgenes (ova or luc) we
performed an additional experiment in which a single vector
(Ad5-luc) was administered by the ig route to C57Bl/6 mice.
After harvesting tissues—Peyer’s patches, distal small intestine
and cecum—the lysates were split for assay of bioluminescence
by luminometry and luc transcripts by RT-qPCR. We observed
that luc transcripts were detectable in all three tissues, with
relatively higher levels being found in Peyer’s patch than in small
intestine (Figure 5A), in keeping with observations made for
ova mRNA (Figure 4B). As regards bioluminescence, however,
higher photon flux, as normalized to protein concentration, was
observed in the cecum than in the small intestine (Figure 5B).
To capture the relationship between levels of luc mRNA
and bioluminescence in the different tissues, specific activity
(photons/s/µg total protein) was plotted as a function of
relative levels of luc transcripts (Figure 5C). Generally speaking,
relatively low levels of luc mRNA in cecum gave rise to
relatively high levels of bioluminescence, while relatively high
levels of luc mRNA in Peyer’s patches gave rise to relatively
low levels of bioluminescence. These observations suggest that
post-transcriptional regulation of transgene expression might
differ between Peyer’s patches and cecum. In this particular
experiment, both luc mRNA and bioluminescence were low for
the small intestine, possibly because the tissue samples collected
for analysis did not coincide with highly transduced zones.
After Intragastric Administration of
HAdV-5-Based Vectors,
Transgene-Encoded Protein Is Produced in
the Intestinal Epithelium
To characterize the cells in which transgene-encoded protein is
expressed, equal doses of two HAdV-5-based vectors, expressing
luc or GFP, were co-administered by the ig route to C57Bl/6 and
BALB/c mice. After immunolabeling with antibodies directed
against luc and analysis by fluorescence microscopy, expression
of luc and GFP was observed within cells located in the
epithelium of both cecum (Figure 6A) and distal small intestine
(Figure 6B).
Selective Binding of Fluorescent-Labeled
HAdV-5 to Intestinal Mucosa and
Translocation of Alexa488-Ad5 across
Intestinal Mucosa via M-Cells after 1 h
One hour after inoculation of Alexa488-labeled HAdV-
5 (Alexa488-Ad5) into ligated intestinal loops, the latter
were immuno-stained for the macrophage and DC marker
CD11c and analyzed by laser scanning confocal microscopy
(Figures 7Ai–iv). Alexa488-Ad5 was observed to be
concentrated at discrete sites at the apical surface of the
FAE, but to be absent from the SED region (Figures 7Ai,ii).
Thus, HAdV-5 appeared to interact with particular cells in the
Peyer’s patch epithelium at the 1 h time point.
To characterize binding of Alexa488-Ad5 to the FAE, tissue
sections were stained with anti-CD11c and, to visualize M
cells, with the UEA-1 lectin microscopy (Figures 7Bi–ix). Image
analysis revealed that Alexa488-Ad5 and UEA-1 co-localized,
suggesting that Alexa488-Ad5 had selectively adhered to M cells
(Figures 7Biii,iv) overlaying the SED region. Moreover, higher
magnification revealed that Alexa488-Ad5 was internalized by M
cells (Figures 7Bv–vii), most likely as intact particles displaying
preserved fluorescence. Consistent with the capacity of M cells
to transport large antigens including viruses and bacteria in the
absence of degradative processes, the 3D acquisition on one
M cell showed a virus being released at the basolateral surface
(Figure 7Bix), suggesting that at the 1 h time point, Alexa488-
Ad5 is available to immune cells present in the SED region of the
FAE.
Capture of Fluorescent-Labeled HAdV-5 by
Peyer’s Patch Phagocytes in SED of
Intestinal Mucosa after 4 h
Four hours after inoculation of Alexa488-Ad5 in the ileal loop,
imaging revealed that Alexa488-Ad5 had been captured by
CD11c+ cells located in the SED region of intestinal mucosa
(Figures 7Ci,ii). Little virus was observed in association with
other cells that did not express the CD11c marker. The 3D
acquisition of individual CD11c+ cells revealed that the virus
had been internalized (Figures 7C, iii,iv), with the intensity
of intracellular staining suggesting that viral particles had
accumulated in particular intracellular compartments.
Capture of Fluorescent-Labeled HAdV-5 by
Lysozyme-Positive Peyer’s Patch
Phagocytes of Intestinal Mucosa after 24 h
Cryosections of apex ceci and Peyer’s patches, collected 24 h after
ig administration of Alexa488-Ad5, were labeled with antibodies
specific for CD11c and lysozyme, expression of the latter reported
to distinguish the largest subset of highly phagocytic DCs in
murine Peyer’s patches (Lelouard et al., 2010). Imaging revealed
that Alexa488-Ad5 had been captured within the Peyer’s patch
(Figure 8A) by numerous cells (Figures 8Bi,ii).Most, if not all, of
the cells bearing Alexa488-Ad5, or fluorescent structural proteins
thereof, expressed both CD11c and lysozyme (Figures 8Biii–vi).
DISCUSSION
To acquire a better understanding of the fate of viral-vectored
vaccines in the intestinal milieu, we tracked HAdV-5-based
vectors expressing reporter proteins or model antigens at whole
body, tissue, and cellular scales after ig administration in
mice. At the whole body level, transgene expression—whether
evaluated by RT-qPCR or bioluminescence imaging—was not
observed in extra-intestinal tissues, such as liver and spleen,
although these two organs are highly transduced after parenteral
administration of HAdV-5-based vectors. Both lymph nodes
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FIGURE 5 | Concurrent evaluation of transgene-specific enzymatic activity and mRNA expression level. Ad5-luc, described in the legend to Figure 1, was
administered (1 × 109 TCID50) to C57Bl/6 mice by the intragastric route. Twenty-four hours later mice were euthanized and tissues–including Peyer’s patches, distal
small intestine and cecum–were collected. Following tissue disruption, homogenates were divided for extraction of total RNA and quantification of luc transcripts (A)
or analysis of luc activity by luminometry (B). (A) The relative expression level of luc RNA was determined by the 211CT method, after normalization against β-actin
transcripts and relative to that of a positive internal reference tissue, and expressed as relative units. (B) Luciferase activity was normalized to protein concentration
and expressed as specific activity (photons/s/µg total protein). Medians are indicated in (A,B). (C) Bioluminescence is plotted for individual tissues as a function of luc
mRNA level. **P < 0.01; as determined by the Wilcoxon-Mann-Whitney test.
FIGURE 6 | Transgene expression at the cellular scale. Non-replicative HAdV-5-based vectors expressing firefly luciferase (Ad5-luc) or green fluorescent protein
(Ad5-gfp), were co-administered (5 × 108 TCID50 of each) to mice by the intragastric route. Following bioluminescence imaging—performed as described in the
legend of Figure 1—bioluminescent zones of cecum and distal small intestine were collected from C57Bl/6 (A) and BALB/c (B) mice, respectively, and processed for
fluorescence microscopy. Cryosections were stained with antibodies directed against luciferase (orange) and 4′,6-diamidino-2-phenylindole (DAPI; blue).
and a gut vascular barrier have been described to confine non-
invasive luminal bacteria to the intestine (Macpherson and
Uhr, 2004; Macpherson et al., 2009; Spadoni et al., 2015), and
might possibly restrict access of non-replicative viral particles to
lymphatics and blood, respectively.
At the tissue scale, transgene expression—as visualized by
bioluminescence imaging—took the form of multiple small
bioluminescent foci found primarily in the distal small intestine,
cecum and colon. This suggested that the vector crossed the
epithelium at multiple sites in different zones of the intestine,
whence it was able to transduce cells and produce transgene-
encoded protein. The difference in total photon flux among zones
was related to variation in the number of bioluminescent foci,
as well as to their average radiance and surface area, which we
interpret as meaning that the number of productive crossing
events and the subsequent level of production of transgene-
encoded protein differed in various zones of the intestine. The
cecum emerged as a zone of high transgene expression, and
may thus represent a major sampling site for HAdV-5 upon ig
delivery, andmore generally a largely overlooked tissue as regards
penetration of luminal viruses and potentially other particulate
antigen.
Of note, bioluminescence rarely coincided with visible Peyer’s
patches or with the functionally related cecal patch, which is
the major site of organized lymphoid tissue in the cecum.
Given the importance of Peyer’s patches in the entry of several
enteric viruses and of particulate antigen in general, this result
was unexpected. Nevertheless, bioluminescence imaging only
permitted observation of crossing events that led to production of
enzymatically active luc. Had crossings often been unproductive;
that is, not led to uptake by permissive cells and production of
transgene-encoded protein, the number of crossing events would
have been underestimated. Such indeed appeared to be the case,
for when transgene expression was assessed by RT-qPCR, the
Peyer’s patches emerged as major sites of transgene expression,
albeit only at the level of mRNA.
We initially considered it possible that luc had indeed been
produced in Peyer’s patches, but that bioluminescence had not
been observed because local concentrations of enzymatic co-
factors (ATP and O2) or substrate (luciferin) were insufficient.
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FIGURE 7 | Interaction of HAdV-5 viral particles with the intestinal mucosa. Fluorescent capsid-labeled HAdV-5 particles (1 × 1011 physical particles) were inoculated
into ligated intestinal loops comprising a Peyer’s patch. Tissue was collected after 1 (A,B) or 4 h (C) and processed for immunohistochemistry, prior to analysis by
laser scanning confocal microscopy. (A) View of the entire Peyer’s patch with (i) and without (ii) Nomarski, and zoom of selected area of Ai with (iii) and without
(iv) Nomarski. Labeled HAd5 (green) and staining for CD11c (magenta) and DAPI (blue) are shown. (B) View of the entire Peyer’s patch in a neighboring section with (i)
and without (ii) Nomarski, and zoom (4×) of selected area of (Bi) with (iii) and without (iv) Nomarski. (v–vii) 3D acquisition of an M cell indicated in (iv). (viii) View of a
portion of the FAE on a section neighboring that shown in (Bi). (ix) Zoom on M cell indicated in (viii). Labeled HAdV-5 (green) and staining for UEA-1 (red) and CD11c
(blue) are shown. (C) (i) View of the entire SED with Nomarski (i). (ii) Zoom of selected area of Ci. (iii,iv) 3D acquisition of two CD11c+ cells from (Cii). Labeled
HAdV-5 (green) and staining for UEA-1 (red in i,ii) and CD11c (magenta) are shown.
We were able to rule out this possibility, however, as when co-
factors and substrate were provided directly to homogenates of
Peyer’s patches, specific activity of luc remained low in relation
to the quantity of luc transcripts. We thus hypothesize that viral
gene expression was subjected to post-transcriptional regulation
within at least some cellular targets of HAdV-5 in Peyer’s patches.
It may be speculated that such regulation is related to robust anti-
viral defenses deployed to limit infection in a tissue rendered
vulnerable by its antigen sampling activity, or possibly represents
a homeostatic mechanism limiting induction of active immunity.
As regards the pathways used to cross the intestinal
epithelium, passage of several enteric viruses has been proposed
to depend upon Peyer’s patches, and more particularly, the M
cells of the FAE (Wolf et al., 1981; Gonzalez-Hernandez et al.,
2014; Kolawole et al., 2015). This pathway appears to be taken
by fluorescent-labeled HAdV-5-based particles as well, as in our
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FIGURE 8 | Tracking HAdV-5 after intragastric administration. Fluorescent capsid-labeled HAdV-5 particles (2 × 1011 physical particles) were administered to
C57Bl/6 mice by the intragastric route. Twenty-four hours later mice were euthanized and tissues were collected and processed for immunohistochemistry, prior to
analysis by fluorescent microscopy (A) and laser scanning confocal microscopy (B). (A) View of the entire intestinal section including a Peyer’s patch with phase
contrast. DAPI (blue) and lysozyme (red) are shown. (B) Zoom of selected areas of A(i,ii) and zoom on a representative cell from B(ii) that has captured
fluorescent-labeled HAdV-5 particles (iii–vi). Fluorescent-labeled HAdV-5 (green) and staining for DAPI (blue), lysozyme (red) and CD11c (magenta) are shown.
study these could be observed to adhere selectively to M cells
in ligated intestinal loops. Such particles were rapidly taken
up by mononuclear phagocytes within the SED, most or all of
which appeared to express lysozyme and thus were likely to
correspond to the subset of mononuclear phagocytes expressing
lysozyme M (LysoDC) described by Lelouard et al. (2010). These
cells may have captured viral particles that had gained entry
to the SED after trancytosis by M cells, or may have seized
viral particles from within the lumen via transepithelial dendrites
before retracting back into the SED (Lelouard et al., 2012).
The dearth of fluorescent particles in other cell types was
striking, and posed the question of whether uptake of HAdV-
5 particles by LysoDC might be receptor-mediated. If so, it
is unlikely that CAR and αv integrins—cell surface-expressed
molecules described to be high-affinity attachment (Bergelson
et al., 1997) and internalization receptors (Wickham et al., 1993),
respectively, for HAd5V—were involved. Indeed, while these
molecules are required for high level transduction of highly
permissive cell lines, they are unnecessary for transduction of
murine DCs (Cheng et al., 2007). Natural IgM antibodies found
in sera of mice are known to bind to HAdV-5 particles and
promote uptake by Kupffer cells (Qiu et al., 2015). It may be
speculated that natural antibodies or other opsonins are able to
bind to luminal HAdV-5 and promote adhesion toM cells and/or
mononuclear phagocytes of the SED. Although fluorescent
vector particles, or structural proteins thereof, were readily
detected within mononuclear phagocytes of the SED, strikingly,
expression of transgene-encoded protein was not. Similar to
conclusions drawn for commensal and pathogenic bacteria
(Kadaoui and Corthésy, 2007; Schenk and Mueller, 2007), these
cells might constitute yet another firewall against expression of
viral genes and hence viral infection. Their role may be analogous
to that of Kupffer cells, which sequester systemically delivered
adenovirus-based vectors from the bloodstream and limit
transgene expression (Khare et al., 2013). Thus, translocation of
luminal HAdV-5 into Peyer’s patchmight represent an impasse in
induction of an immune response to transgene-encoded antigen.
In addition to passage across the intestinal epithelium at
canonical sites—the FAE of Peyer’s patches—our results imply
that the vector transduced cells after passage at non-canonical
sites. It is of course possible that the bioluminescent foci
lying outside prominent Peyer’s patches and the cecal patch
corresponded to FAE overlying isolated follicles, and that the
processes involved in penetration were analogous within and
without Peyer’s patches. Nevertheless, transgene expression was
observed in epithelial cells that did not lie in immediate proximity
to lymphoid follicles, suggesting that the vector had in some—
and perhaps many—instances transduced cells in the villous
epithelium rather than the Peyer’s patch. Transgene production
in intestinal epithelium has also been noted after introduction
of HAdV-5 in the intestinal lumen of rats (Cheng et al., 1997;
Foreman et al., 1998). While transduction of epithelial cells could
theoretically have been secondary to entry by either apical or
basolateral poles, weak expression of CAR and αv integrins at the
apical surface of differentiated intestinal epithelial cells is likely to
limit entry and transduction of luminal HAdV-5 particles (Walter
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et al., 1997; Croyle et al., 1998b; Lecollinet et al., 2006). As regards
possible transduction at the basolateral pole, luminal vector may
have been taken up by dendritic extensions and handed off after
retraction through the epithelium. Alternatively, opsonization
of vectors may conceivably have promoted interactions with
antigen-shuttling receptors at the luminal surface of villous
epithelium or with dendritic extensions of phagocytes, and thus
enhanced apical or basolateral entry, respectively.
Regarding the higher systemic immune response observed
after im administration of Ad5-ova, the greater portion of
inoculated HAd5-derived vector is confined to the injected
muscle and draining lymph nodes thereof (Hemmi et al., 2014).
Moreover, the overwhelmingly majority of transgene-encoded
protein is produced in the same location; that is, injected muscle
and draining lymph nodes (Yang et al., 2003; Kaufman et al.,
2010). In the draining lymph nodes, antigen appears to be
selectively expressed in conventional DCs (Lindsay et al., 2010;
Dicks et al., 2015). Transgene expression is prolonged (Finn
et al., 2009), as is presentation of transgene-encoded antigen
to antigen-specific CD8+ T cells (Yang et al., 2006; Tatsis
et al., 2007). Both prolonged transgene expression and antigen
presentation by hematopoietic antigen presenting cells are
required for optimum priming of the CD8+ T cell response (Finn
et al., 2009; Bassett et al., 2011). It can be reasonably hypothesized
that a key difference between im and ig immunization is that
the former supports sufficient transduction of cDCs in secondary
lymphoid tissue such that immune responses may be primed,
while the latter does not. In keeping with this interpretation,
superior immunogenicity of HAdV-5 as compared with human
adenoviruses of species E has been associated with substantially
higher levels of transgene expression, particularly within draining
lymph nodes, after im administration in mice (Dicks et al., 2015).
In conclusion, after ig administration of HAdV-5-based
vectors in mice, a large number of crossing events took place
throughout the intestine within and without Peyer’s patches.
Nevertheless, multiple firewalls restricted systemic dissemination
of vector and translation of transgene-encoded protein, notably
in Peyer’s patches. Since the organized lymphoid tissue of Peyer’s
patches are critical sites for induction of intestinal immune
responses, strict repression of translation of viral mRNA after
passage via the FAE of Peyer’s patches would be expected
to restrict immune responses generated to transgene-encoded
antigen after oral delivery. Optimization of immune responses
elicited by non-replicative versions of HAdV-5, and possibly
other viral vectors, is likely to require enhanced production
of transgene-encoded protein in the gastrointestinal milieu,
potentially by eluding capture by mononuclear phagocytes and
promoting transduction of other cell types.
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